Guanine &agr;‐carboxy nucleoside phosphonate (G‐&agr;‐CNP) shows a different inhibitory kinetic profile against the DNA polymerases of human immunodeficiency virus (HIV) and herpes viruses

[1]  J. Deval,et al.  New antiviral approaches for respiratory syncytial virus and other mononegaviruses: Inhibiting the RNA polymerase. , 2016, Antiviral research.

[2]  G. Andrei,et al.  Distribution and effects of amino acid changes in drug-resistant α and β herpesviruses DNA polymerase , 2016, Nucleic acids research.

[3]  L. Naesens,et al.  The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design , 2016, Medicinal research reviews.

[4]  Guangdi Li,et al.  Approved Antiviral Drugs over the Past 50 Years , 2016, Clinical Microbiology Reviews.

[5]  E. Arnold,et al.  Conformational States of HIV-1 Reverse Transcriptase for Nucleotide Incorporation vs Pyrophosphorolysis-Binding of Foscarnet. , 2016, ACS chemical biology.

[6]  J. Feld,et al.  Direct-acting antiviral agents for hepatitis C: structural and mechanistic insights , 2016, Nature Reviews Gastroenterology &Hepatology.

[7]  R. Kuchta,et al.  Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA. , 2016, Biochemistry.

[8]  M. Yuen,et al.  DNA polymerase inhibitors for treating hepatitis B: a safety evaluation , 2016, Expert opinion on drug safety.

[9]  J. Balzarini,et al.  Lipophilic prodrugs of nucleoside triphosphates as biochemical probes and potential antivirals , 2015, Nature Communications.

[10]  F. Luciani,et al.  Inhibitors of the Hepatitis C Virus Polymerase; Mode of Action and Resistance , 2015, Viruses.

[11]  L. Naesens,et al.  Alpha-carboxy nucleoside phosphonates as universal nucleoside triphosphate mimics , 2015, Proceedings of the National Academy of Sciences.

[12]  A. Maguire,et al.  Design and synthesis of α-carboxy nucleoside phosphonate analogues and evaluation as HIV-1 reverse transcriptase-targeting agents. , 2015, The Journal of organic chemistry.

[13]  N. Sluis-Cremer,et al.  Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors , 2013, Biomolecules.

[14]  J. Bernatchez,et al.  Formation of a Quaternary Complex of HIV-1 Reverse Transcriptase with a Nucleotide-competing Inhibitor and Its ATP Enhancer* , 2013, The Journal of Biological Chemistry.

[15]  K. Hostetler,et al.  Application of kinase bypass strategies to nucleoside antivirals. , 2011, Antiviral research.

[16]  G. Andrei,et al.  Emerging drugs for varicella-zoster virus infections , 2011, Expert opinion on emerging drugs.

[17]  M. Götte,et al.  Effects of mutations F61A and A62V in the fingers subdomain of HIV-1 reverse transcriptase on the translocational equilibrium. , 2011, Journal of molecular biology.

[18]  M. Radi,et al.  HIV-1 RT Inhibitors with a Novel Mechanism of Action: NNRTIs that Compete with the Nucleotide Substrate , 2010, Viruses.

[19]  Roger A. Jones,et al.  Structural Basis for the Role of the K65R Mutation in HIV-1 Reverse Transcriptase Polymerization, Excision Antagonism, and Tenofovir Resistance* , 2009, The Journal of Biological Chemistry.

[20]  J. Mellors,et al.  Anti-Human Immunodeficiency Virus Activity, Cross-Resistance, Cytotoxicity, and Intracellular Pharmacology of the 3′-Azido-2′,3′-Dideoxypurine Nucleosides , 2009, Antimicrobial Agents and Chemotherapy.

[21]  E. De Clercq,et al.  Drug targets in cytomegalovirus infection. , 2009, Infectious disorders drug targets.

[22]  S. L. Le Grice,et al.  Mutations M184V and Y115F in HIV-1 Reverse Transcriptase Discriminate against “Nucleotide-competing Reverse Transcriptase Inhibitors”* , 2008, Journal of Biological Chemistry.

[23]  N. Sluis-Cremer,et al.  Mechanisms of inhibition of HIV replication by non-nucleoside reverse transcriptase inhibitors. , 2008, Virus research.

[24]  M. Götte.  Mechanisms of resistance associated with excision of incorporated nucleotide analogue inhibitors of HIV-1 reverse transcriptase , 2007, Current opinion in HIV and AIDS.

[25]  K. Hertogs,et al.  Indolopyridones Inhibit Human Immunodeficiency Virus Reverse Transcriptase with a Novel Mechanism of Action , 2006, Journal of Virology.

[26]  J. Balzarini,et al.  Aryl furano pyrimidines: the most potent and selective anti-VZV agents reported to date. , 2006, Antiviral research.

[27]  J. Balzarini,et al.  Application of the cycloSal-prodrug approach for improving the biological potential of phosphorylated biomolecules. , 2006, Antiviral research.

[28]  C. Manichanh,et al.  Human herpesvirus 6 DNA polymerase: enzymatic parameters, sensitivity to ganciclovir and determination of the role of the A961V mutation in HHV-6 ganciclovir resistance. , 2004, Antiviral research.

[29]  J. Courcambeck,et al.  A Loss of Viral Replicative Capacity Correlates with Altered DNA Polymerization Kinetics by the Human Immunodeficiency Virus Reverse Transcriptase Bearing the K65R and L74V Dideoxynucleoside Resistance Substitutions* , 2004, Journal of Biological Chemistry.

[30]  B. Marchand,et al.  Site-specific Footprinting Reveals Differences in the Translocation Status of HIV-1 Reverse Transcriptase , 2003, Journal of Biological Chemistry.

[31]  V. Prasad,et al.  Substitutions of Phe61 Located in the Vicinity of Template 5′-Overhang Influence Polymerase Fidelity and Nucleoside Analog Sensitivity of HIV-1 Reverse Transcriptase* , 2002, The Journal of Biological Chemistry.

[32]  H. Gross,et al.  Localization of the Active Site of HIV-1 Reverse Transcriptase-associated RNase H Domain on a DNA Template Using Site-specific Generated Hydroxyl Radicals* , 1998, The Journal of Biological Chemistry.

[33]  J. Cherrington,et al.  Expression of the catalytic subunit (UL54) and the accessory protein (UL44) of human cytomegalovirus DNA polymerase in a coupled in vitro transcription/translation system. , 1997, Protein expression and purification.

[34]  T. Cihlar,et al.  Nucleoside and nucleotide HIV reverse transcriptase inhibitors: 25 years after zidovudine. , 2010, Antiviral research.

[35]  E. De Clercq,et al.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs): past, present, and future. , 2004, Chemistry & biodiversity.

[36]  P. Boehmer.  Expression, purification, and characterization of the herpes simplex virus type-1 DNA polymerase. , 1996, Methods in enzymology.

[37]  S. L. Le Grice,et al.  Rapid purification of homodimer and heterodimer HIV-1 reverse transcriptase by metal chelate affinity chromatography. , 1990, European journal of biochemistry.